Masimo Corp
NASDAQ:MASI
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
92.89
172.96
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Masimo Corp
Masimo Corp
Total Liabilities
Masimo Corp
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Masimo Corp
NASDAQ:MASI
|
Total Liabilities
$1.6B
|
CAGR 3-Years
76%
|
CAGR 5-Years
51%
|
CAGR 10-Years
21%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Total Liabilities
$31.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
16%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Liabilities
$17.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
6%
|
|
|
Stryker Corp
NYSE:SYK
|
Total Liabilities
$23.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
|
|
Abbott Laboratories
NYSE:ABT
|
Total Liabilities
$33.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
6%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Liabilities
$2.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
14%
|
|
Masimo Corp
Glance View
Masimo Corp. is a pioneering medical technology company that specializes in innovative non-invasive monitoring solutions. Founded in 1989 and headquartered in Irvine, California, Masimo revolutionized the field of patient monitoring with its groundbreaking pulse oximetry technology, which provides accurate blood oxygen saturation levels in a wide range of settings, from hospitals to home care. The company has continued to expand its product portfolio, introducing advanced monitoring solutions that measure multiple physiological parameters critical for patient care. With a strong emphasis on research and development, Masimo maintains a competitive edge, driving both innovation and customer loyalty across the global healthcare market. For investors, Masimo presents a compelling growth story. As the demand for effective remote patient monitoring rises, driven by trends in telehealth and an aging population, the company is well-positioned to capitalize on these opportunities. Masimo's focus on integrating sophisticated technologies, such as measure-through motion and low perfusion capabilities, sets it apart from traditional monitoring devices. Moreover, with a solid financial foundation and a history of steady revenue growth, Masimo continues to demonstrate resilience in the face of market challenges. This combination of innovation, market demand, and financial stability makes Masimo Corp. an intriguing option for investors looking to tap into the evolving landscape of healthcare technology.
See Also
What is Masimo Corp's Total Liabilities?
Total Liabilities
1.6B
USD
Based on the financial report for Sep 28, 2024, Masimo Corp's Total Liabilities amounts to 1.6B USD.
What is Masimo Corp's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
21%
Over the last year, the Total Liabilities growth was -6%. The average annual Total Liabilities growth rates for Masimo Corp have been 76% over the past three years , 51% over the past five years , and 21% over the past ten years .
You don't have any saved screeners yet
